Megestrol Market
Global Megestrol Market Size, Share and Trends Analysis Report by Type (Oral Suspension, Tablet, Injection, and Others), By Application (Hospital, Clinic, and Others) Forecast Period (2022-2028) Update Available - Forecast 2024-2030
The global megestrol market is expected to grow with a significant growth rate during the forecast period(2022-2028). Progesterone, a human hormone, is used to treat breast cancer and endometrial cancer with megestrol. It alters female hormones that contribute to cancer growth and aids in weight gain by increasing hunger. The rising prevalence of breast cancer among women is a prominent factor driving the market growth. Breast cancer is the most frequent cancer globally, according to the World Health Organization (WHO), accounting for 12% of all new cancer cases in 2021. Furthermore, according to US Breast Cancer Statistics, around 1 in every 8 US women (13%) may acquire invasive breast cancer during their lifetime. According to the same source, an estimated 287,850 new cases of invasive breast cancer and 51,400 new instances of non-invasive breast cancer will be identified in women in the US in 2022, with a fatality rate of 43,250 women. As a result, the global megestrol market is being driven by the increased prevalence of breast cancer among women. Apart from this, the rising competition among market players and government fluctuations in product standards may restrain the market growth.
Segmental Outlook
The global megestrol market is segmented based on type and application. Based on type, the market is sub-segmented into oral suspension, tablet, injection, others. Based on application, the market is sub-segmented into hospitals, clinics, and others.
Global Megestrol Market Share by Type, 2021(%)
Oral Suspension Segment is holding a Prominent Share in the Global Megestrol Market.
Based on type, oral suspension has seen an increase in the market in 2021. Megestrol acetate (Megace ES) oral suspension was created by Par Pharmaceutical for the treatment of anorexia, cachexia, and substantial weight loss associated with AIDS. Megestrol acetate oral suspension is a type of the female hormone progesterone used to treat anorexia, wasting (cachexia), or unexplained, severe weight loss in patients with an acquired immunodeficiency syndrome diagnosis (AIDS). The rising demand for oral suspension megestrol in AIDS treatment is the prominent factor enhancing the market growth.
Regional Outlooks
The global megestrol market is further segmented based on geography Including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East and Africa, and Latin America).
Global Megestrol Market Growth, by Region 2022-2028
Asia-Pacific Region is Estimated to Hold the Major Share in the Global Megestrol Market
The global megestrol market has been led by Asia-Pacific, and this trend is expected to continue over the forecast period. Asia-Pacific major countries such as China, India, Japa have been recognized as a promising locations for low-cost drug research due to their rapidly increasing healthcare infrastructure along with supportive government initiatives, low operating expenses, and growing patient population. In March 2018, the central government in India approved the implementation of PM-JAY. This flagship public health initiative offers hospital coverage for the 40 percent of the country’s population that is poor or low-income.
Market Players Outlook
The major companies serving the global megestrol Market include Pfizer Inc. Ltd., Novartis International AG, Abbott Alkaloidal Co., Takeda Chemical Industries, Ltd., and others. To enhance their market share, industry participants are employing a number of critical techniques. In December 2021, Takeda announced the launch of LIVTENCITY (maribavir), its second new molecular entity approved by the U.S. FDA in FY2021, following the EXKIVITY (mobocertinib) approval and launch in Q2 FY2021. LIVTENCITY is a novel molecular entity that inhibits viral DNA replication, encapsidation, and nuclear egress by targeting CMV at pUL97.
The Report Covers
- Market value data analysis of 2022 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the Global Megestrol Market. Based on the availability of data, information related to new product launches, and relevant news is additionally available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global Megestrol Market
- Recovery Scenario of Global Megestrol Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Pfizer Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Novartis International AG
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Abbott Laboratories
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Takeda Chemical Industries, Ltd.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Par Pharmaceutical
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Megestrol Market By Type
4.1.1. Oral Suspension
4.1.2. Tablet
4.1.3. Injection
4.1.4. Others
4.2. Global Megestrol Market By Application
4.2.1. Hospital
4.2.2. Clinic
4.2.3. Others
5. Regional Analysis
5.1. North America
5.1.1 United States
5.1.2 Canada
5.2. Europe
5.2.1.UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Actiza Pharmaceutical Pvt. Ltd.
6.2. Akorn Operating Co. LLC
6.3. Apo-Atorvastatin Co. Ltd.
6.4. Breckenridge Pharmaceutical, Inc Subsidiary Towa Pharmaceutical
6.5. Bristol-Myers Co.
6.6. Grand Pharmaceutical Group Ltd.
6.7. GlaxoSmithKline Plc
6.8. Milan or Mylan N.V
6.9. Mayne Nickless acquired by F H Faulding & Co Ltd.
6.10. Nhwa group ltd
6.11. Now Wockhardt Ltd.
6.12. Par Pharmaceutical-(Endo International ltd)
6.13. Qingdao sea biological Pharmaceutical Co., Ltd.
6.14. Sandoz International GmbH
6.15. Twi Pharmaceuticals
6.16. Teva Middle East Pharmaceutical & Chemical Works Co.
6.17. West-ward pharm ltd
6.18. Xi'an Gerui Pharmaceutical Co., Ltd.
6.19. Zhejiang Xianju Pharmaceutical Co.,Ltd.
1. GLOBAL MEGESTROL MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL ORAL SUSPENSION IN MEGESTROL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL TABLET IN MEGESTROL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL INJECTION IN MEGESTROL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL OTHERMEGESTROL TYPES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL MEGESTROL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
7. GLOBAL MEGESTROL IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
8. GLOBAL MEGESTROL IN CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
9. GLOBAL MEGESTROL IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
10. GLOBAL MEGESTROL MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028($ MILLION)
11. NORTH AMERICAN MEGESTROL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN MEGESTROL MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
13. NORTH AMERICAN MEGESTROL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
14. EUROPEAN MEGESTROL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. EUROPEAN MEGESTROL MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028($ MILLION)
16. EUROPEAN MEGESTROL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC MEGESTROL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC MEGESTROL MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC MEGESTROL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. REST OF THE WORLD L MEGESTROL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. REST OF THE WORLD MEGESTROL MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
22. REST OF THE WORLD MEGESTROL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL MEGESTROL MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL MEGESTROL MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL MEGESTROL MARKET, 2021-2028 (%)
4. GLOBAL MEGESTROL MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL ORAL SUSPENSION IN MEGESTROL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL TABLET IN MEGESTROL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL INJECTION IN MEGESTROL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL OTHERMEGESTROL TYPES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL MEGESTROL MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
10. GLOBAL MEGESTROL IN HOSPITAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL MEGESTROL IN CLINIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL MEGESTROL IN OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL MEGESTROL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. US MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
15. CANADA MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
16. UK MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
17. FRANCE MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
18. GERMANY MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
19. ITALY MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
20. SPAIN MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
21. REST OF EUROPE MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
22. INDIA MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
23. CHINA MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
24. JAPAN MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
25. SOUTH KOREA MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF ASIA-PACIFIC MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF THE WORLD MEGESTROL MARKET SIZE, 2021-2028 ($ MILLION)
